BMS Directors Ramp Up Deferred‑Unit Buying, Signaling Strong Long‑Term Confidence in Drug Pipeline and Share Price Momentum
Insider buying of BMS deferred units signals long‑term confidence, boosting shares toward their 52‑week high and supporting the company’s drug‑pipeline outlook.
3 minutes to read
